CAR-T Meeting 2023 | Novel off-the-shelf CARs: where may these agents fit in the hemonc treatment landscape?
Jürgen Kuball
• 10 Feb 2023
Jürgen Kuball, MD, PhD, Utrecht University, Utrecht, The Netherlands, briefly comments on the promise of novel off-the-shelf CAR-T products and where these may fit in the treatment of hematological malignancies. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Dr. Kuball reports grants from Gadeta, Novartis, and Miltenyi Biotech, and is the inventor on patents dealing with γδT cell-related aspects, as well as the co-founder and shareholder of Gadeta.
